No Catastrophes at Novartis
295237
Novartis stays on track with its third-quarter results.
299447
NORTON -- Sometimes, changes are good. Which is why there will be no change of venue for the Deutsche Bank Championship.
479318
A spokesperson for the Acoustic Neuroma Association says the group sees little cause for concern. In addition, information provided to the group by the medical community has not shown an increase
250837
U.S. regulators have not approved Novartis AG's Prexige painkiller, the Swiss drugmaker said on Thursday, a move that had been expected after Australia withdrew the drug on concerns over liver side-effects.
184248
Averse to risk? Check out these nontraditional drug companies.
492501
The biopharmaceutical company removes some uncertainty by teaming up with Novartis.
89688
The Institute of Environmental Medicine (IMM) at Karolinska Institute in Sweden found no indications of risk for less than 10 years of usage.
435276
The troubled pharmaceutical company begins to show signs of life.
242631
By Bill Graham, The Kansas City Star, Mo.  Jun. 25--Explosions and a fire Sunday at a chemical plant in Richmond left no air pollution problems that could harm residents or firefighters, a spokesman for the Environmental Protection Agency said today.
677326
BASEL, Switzerland  - Swiss drugmaker Novartis AG  missed forecasts with a 42 percent drop in fourth-quarter net profit, hit by generic competition and a one-off restructuring charge, sending its shares lower.
446140
There&#39;s no health crisis in the United States despite the flu shot shortage, Secretary of Health and Human Services Tommy Thompson told reporters Monday.
455059
No one hurt as small device leaves minor damage.
39009
Novartis AG failed to give the government prompt, accurate reports about deaths of dogs treated with a painkiller in the same class of medicines now linked to heart problems in humans, US regulators have charged in a letter.
593038
Clinical trial results show significant   benefits for patients with relapsing multiple sclerosis treated   with Novartis's experimental FTY720 medicine, the company said   late on Wednesday.
261717
Novartis AG, Switzerland&#39;s largest drugmaker, said the US Food and Drug Administration has delayed approval of its Certican transplant treatment and is seeking more information on safe and effective dosing.
10160
Novartis Pharmaceuticals Corp., the U.S. unit of Swiss drugmaker Novartis AG, said Thursday that at least three out of four patients given an experimental multiple sclerosis treatment were free of relapses for more than two years.
310103
Novartis' pain killer Prexige did not  raise the rate of serious heart issues and led to fewer ulcer  problems compared to normal anti-inflammatory drugs, results of  a study of over 18,000 patients showed.